Azetidines
- (4)
- (1)
- (13)
- (10)
- (1)
- (3)
- (3)
- (12)
- (12)
- (2)
- (59)
- (13)
- (46)
- (2)
- (3)
- (6)
- (4)
- (4)
- (2)
- (5)
- (2)
- (4)
- (3)
- (6)
- (4)
- (1)
- (4)
- (2)
- (4)
- (10)
- (2)
- (13)
- (7)
- (4)
- (5)
- (4)
- (4)
- (6)
Filtered Search Results
3-Hydroxyazetidine hydrochloride, 97%
CAS: 18621-18-6 Molecular Formula: C3H8ClNO Molecular Weight (g/mol): 109.553 MDL Number: MFCD02683887 InChI Key: UQUPQEUNHVVNKW-UHFFFAOYSA-N Synonym: 3-hydroxyazetidine hydrochloride,azetidin-3-ol hydrochloride,3-hydroxyazetidine hcl,azetidin-3-ol hcl,3-azetidinol hydrochloride,azetidin-3-ol hydrochloride salt,3-azetidinol, hydrochloride,3-hydroxy-azetidine hydrochloride,azetidin-3-ol, hydrochloride salt,3-hydroxy-1-azetidine hydrochloride PubChem CID: 2759290 IUPAC Name: azetidin-3-ol;hydrochloride SMILES: C1C(CN1)O.Cl
| PubChem CID | 2759290 |
|---|---|
| CAS | 18621-18-6 |
| Molecular Weight (g/mol) | 109.553 |
| MDL Number | MFCD02683887 |
| SMILES | C1C(CN1)O.Cl |
| Synonym | 3-hydroxyazetidine hydrochloride,azetidin-3-ol hydrochloride,3-hydroxyazetidine hcl,azetidin-3-ol hcl,3-azetidinol hydrochloride,azetidin-3-ol hydrochloride salt,3-azetidinol, hydrochloride,3-hydroxy-azetidine hydrochloride,azetidin-3-ol, hydrochloride salt,3-hydroxy-1-azetidine hydrochloride |
| IUPAC Name | azetidin-3-ol;hydrochloride |
| InChI Key | UQUPQEUNHVVNKW-UHFFFAOYSA-N |
| Molecular Formula | C3H8ClNO |
PF-05085727, MedChemExpress
MedChemExpress PF-05085727 is a potent, selective and brain penetrant inhibitor of cGMP-dependent PDE2A (IC50=2 nM). PF-05085727 inhibits PDE2A >4,000-fold selectivity over PDE1 and PDE3-11.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 413.4 |
|---|---|
| Color | Yellow |
| Physical Form | Solid |
| Chemical Name or Material | PF-05085727 |
| Grade | Research |
| SMILES | CN1C2=NC=NC(N3CCC3)=C2C(C4=C(C5=CC=C(C(F)(F)F)C=C5)N(C)N=C4)=N1 |
| For Use With (Application) | Neuroscience-Neuromodulation |
| Percent Purity | 98.0% |
| CAS | 1415637-72-7 |
| Solubility Information | DMSO : 62.5 mg/mL (151.19 mM; Need ultrasonic) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C20H18F3N7 |
| Formula Weight | 413.4 |
Delgocitinib, MedChemExpress
MedChemExpress Delgocitinib (JTE-052) is a specific JAK inhibitor with IC50s of 2.8, 2.6, 13 and 58 nM for JAK1, JAK2, JAK3 and Tyk2, respectively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 310.35 |
|---|---|
| Color | Off-White |
| Physical Form | Solid |
| Chemical Name or Material | Delgocitinib |
| Grade | Research |
| SMILES | O=C(N(C[C@@H]1C)[C@]21CN(C3=C(C=CN4)C4=NC=N3)CC2)CC#N |
| For Use With (Application) | COVID-19-immunoregulation |
| Percent Purity | 99.75% |
| CAS | 1263774-59-9 |
| Solubility Information | DMSO : ≥ 58 mg/mL (186.89 mM) |
| Synonym | JTE-052 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C16H18N6O |
| Formula Weight | 310.35 |
NSC319726, MedChemExpress
MedChemExpress NSC319726 (ZMC1) is a mutant p53R175 reactivator; inhibits growth of fibroblasts expressing the p53R175 mutation (IC50 = 8 nM); shows no inhibition for p53 wild-type cells.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 234.32 |
|---|---|
| Color | Off-White |
| Physical Form | Powder |
| Chemical Name or Material | NSC319726 |
| Grade | Research |
| SMILES | C/C(C1=NC=CC=C1)=N\NC(N2CCC2)=S |
| For Use With (Application) | Cancer-programmed cell death |
| Percent Purity | 98.06% |
| CAS | 71555-25-4 |
| Solubility Information | DMSO : 31.25 mg/mL (133.36 mM; Need ultrasonic) |
| Health Hazard 1 | H302∣H315∣H319∣H335 |
| Synonym | ZMC1 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C11H14N4S |
| Formula Weight | 234.32 |
PF-05180999, MedChemExpress
MedChemExpress PF-05180999 (PF-999) is a phosphodiesterase 2A (PDE2A) inhibitor, with an IC50 of 1.6 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 414.39 |
|---|---|
| Color | Off-White |
| Physical Form | Solid |
| Chemical Name or Material | PF-05180999 |
| Grade | Research |
| SMILES | CC1=NC(C2=C(C3=CC=C(C(F)(F)F)C=N3)N(C)N=C2)=C4N1N=CN=C4N5CCC5 |
| For Use With (Application) | Neuroscience-Neuromodulation |
| Percent Purity | 98.93% |
| CAS | 1394033-54-5 |
| Solubility Information | DMSO : 50 mg/mL (120.66 mM; Need ultrasonic) |
| Health Hazard 1 | H301∣H315∣H319∣H335 |
| Synonym | PF-999 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C19H17F3N8 |
| Formula Weight | 414.39 |
CNX-2006, MedChemExpress
MedChemExpress CNX-2006 is a mutant-selective and irreversible EGFR inhibitor with an IC50 below 20 nM for EGFRT790M.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 545.53 |
|---|---|
| Color | Gray |
| Physical Form | Solid |
| Chemical Name or Material | CNX-2006 |
| Grade | Research |
| SMILES | C=CC(NC1=CC=CC(NC2=NC(NC3=CC=C(NC4CN(CCF)C4)C=C3OC)=NC=C2C(F)(F)F)=C1)=O |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 99.68% |
| CAS | 1375465-09-0 |
| Solubility Information | DMSO : ≥ 52 mg/mL (95.32 mM) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C26H27F4N7O2 |
| Formula Weight | 545.53 |
Selpercatinib, MedChemExpress
MedChemExpress Selpercatinib (LOXO-292) is a potent, selective RET kinase inhibitor with IC50 values of 14.0 nM, 24.1 nM, and 530.7 nM for RET (WT), RET (V804M), and RET (G810R), respectively. Selpercatinib has anticancer activity.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 525.6 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Selpercatinib |
| Grade | Research |
| SMILES | N#CC1=C2C(C3=CC=C(N4CC(C5)N(CC6=CC=C(OC)N=C6)C5C4)N=C3)=CC(OCC(C)(O)C)=CN2N=C1 |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 98.06% |
| CAS | 2152628-33-4 |
| Solubility Information | DMSO : 62.5 mg/mL (118.91 mM; Need ultrasonic) |
| Synonym | LOXO-292 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C29H31N7O3 |
| Formula Weight | 525.6 |
Siponimod, MedChemExpress
MedChemExpress Siponimod (BAF-312) is an orally active and selective sphingosine-1-phosphate (S1P) receptor modulator. Siponimod is selective for S1P1 and S1P5 over S1P2, S1P3, and S1P4, with EC50s of 0.4, 0.98, >10000, >1000, and 750 nM, respectively. Siponimod can be used for multiple sclerosis (MS) research-.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 516.6 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Siponimod |
| Grade | Research |
| SMILES | O=C(C1CN(CC2=CC=C(/C(C)=N/OCC3=CC=C(C4CCCCC4)C(C(F)(F)F)=C3)C=C2CC)C1)O |
| Percent Purity | 98.0% |
| CAS | 1230487-00-9 |
| Solubility Information | DMSO : ≥ 30 mg/mL (58.07 mM) |
| Health Hazard 1 | H302∣H315∣H319∣H335 |
| Synonym | BAF-312 |
| Purity Grade Notes | Research |
| Recommended Storage | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Shelf Life | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Molecular Formula | C29H35F3N2O3 |
| Formula Weight | 516.6 |
Cobimetinib (R-enantiomer), MedChemExpress
MedChemExpress Cobimetinib R-enantiomer is the less active R-enantiomer of Cobimetinib. Cobimetinib is a potent and selective MEK inhibitor.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Baricitinib, MedChemExpress
MedChemExpress Baricitinib (LY3009104; INCB028050) is a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 371.42 |
|---|---|
| Color | White |
| Physical Form | Powder |
| Chemical Name or Material | Baricitinib |
| Grade | Research |
| SMILES | N#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(S(=O)(CC)=O)C1 |
| For Use With (Application) | COVID-19-immunoregulation |
| Percent Purity | 95.0% |
| CAS | 1187594-09-7 |
| Solubility Information | DMSO : 25 mg/mL (67.31 mM; Need ultrasonic and warming) |
| Synonym | LY3009104 INCB028050 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C16H17N7O2S |
| Formula Weight | 371.42 |
DMP 777, MedChemExpress
MedChemExpress DMP 777 is a potent, selective, and orally active human leukocyte elastase (HLE) inhibitor.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 564.67 |
|---|---|
| Color | Off-White |
| Physical Form | Solid |
| Chemical Name or Material | DMP 777 |
| Grade | Research |
| SMILES | CCC[C@H](C1=CC2=C(C=C1)OCO2)NC(N3[C@H](C(CC)(C3=O)CC)OC4=CC=C(C=C4)C(N5CCN(CC5)C)=O)=O |
| For Use With (Application) | COVID-19-immunoregulation |
| Percent Purity | 98.41% |
| CAS | 157341-41-8 |
| Solubility Information | DMSO : 38.33 mg/mL (67.88 mM; Need ultrasonic) |
| Synonym | L-694458 |
| Purity Grade Notes | Research |
| Recommended Storage | -20°C, stored under nitrogen∣In solvent : -80°C, 6 months∣-20°C, 1 month (stored under nitrogen) |
| Shelf Life | -20°C, stored under nitrogen∣In solvent : -80°C, 6 months∣-20°C, 1 month (stored under nitrogen) |
| Molecular Formula | C31H40N4O6 |
| Formula Weight | 564.67 |
Carbenicillin disodium, MedChemExpress
MedChemExpress Carbenicillin disodium is a beta-lactam penicillin derivative that interference with final stage of bacterial cell wall synthesis.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 422.36 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Carbenicillin disodium |
| Grade | Research |
| SMILES | O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(C(C(O[Na])=O)C3=CC=CC=C3)=O)N1C2=O)O[Na] |
| For Use With (Application) | COVID-19-immunoregulation |
| Percent Purity | 95.0% |
| CAS | 4800-94-6 |
| Solubility Information | H2O : 125 mg/mL (295.96 mM; Need ultrasonic) ∣DMSO : 62.5 mg/mL (147.98 mM; Need ultrasonic) |
| Health Hazard 1 | H317∣H334 |
| Synonym | Sodium carbenicillin |
| Purity Grade Notes | Research |
| Recommended Storage | 4°C, sealed storage, away from moisture and light∣The compound is unstable in solutions, freshly prepared is recommended. |
| Shelf Life | 4°C, sealed storage, away from moisture and light∣The compound is unstable in solutions, freshly prepared is recommended. |
| Molecular Formula | C17H16N2Na2O6S |
| Formula Weight | 422.36 |
Cephalosporin C zinc salt, MedChemExpress
MedChemExpress Cephalosporin C zinc salt is a potent inhibitor of SAMHD1 with an IC50 of 1.1 μM. Cephalosporin C zinc salt also has moderate anti-orthopoxvirus activity.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 478.78 |
|---|---|
| Color | Off-White |
| Physical Form | Solid |
| Chemical Name or Material | Cephalosporin C zinc salt |
| Grade | Research |
| SMILES | CC(OCC1=C(C([O-])=O)N(C([C@H]2NC(CCC[C@@H](N)C([O-])=O)=O)=O)[C@]2([H])SC1)=O.[Zn+2] |
| For Use With (Application) | COVID-19-immunoregulation |
| Percent Purity | 98.0% |
| CAS | 59143-60-1 |
| Solubility Information | DMSO : 5 mg/mL (10.44 mM; ultrasonic and adjust pH to 3 with 1M HCl) |
| Purity Grade Notes | Research |
| Recommended Storage | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Shelf Life | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Molecular Formula | C16H19N3O8SZn |
| Formula Weight | 478.78 |
Baricitinib phosphate, MedChemExpress
MedChemExpress Baricitinib phosphate (LY3009104 phosphate; INCB028050 phosphate) is a selective orally bioavailable JAK1/JAK2 inhibitor with IC50 of 5.9 nM and 5.7 nM, respectively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 469.41 |
|---|---|
| Color | Off-White |
| Physical Form | Powder |
| Chemical Name or Material | Baricitinib phosphate |
| Grade | Research |
| SMILES | N#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(S(=O)(CC)=O)C1.O=P(O)(O)O |
| For Use With (Application) | COVID-19-immunoregulation |
| Percent Purity | 99.29% |
| CAS | 1187595-84-1 |
| Solubility Information | DMSO : ≥ 4.7 mg/mL (10.01 mM) |
| Health Hazard 1 | H302∣H315∣H319∣H335 |
| Synonym | LY3009104 phosphateINCB028050 phosphate |
| Purity Grade Notes | Research |
| Recommended Storage | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Shelf Life | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Molecular Formula | C16H20N7O6PS |
| Formula Weight | 469.41 |
Ceftazidime, MedChemExpress
MedChemExpress Ceftazidime (GR20263), an antibiotic, has a broad spectrum activity against Gram-positive and Gram-negative aerobic bacteria. Ceftazidime is also active against Enterobacteriaceae (including β-lactamase-positive strains) and is resistant to hydrolysis by most β-lactamases.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 546.58 |
|---|---|
| Color | White |
| Physical Form | Powder |
| Chemical Name or Material | Ceftazidime |
| Grade | Research |
| SMILES | O=C1[C@@H](NC(/C(C2=CSC(N)=N2)=N\OC(C)(C(O)=O)C)=O)[C@@]3([H])SCC(C[N+]4=CC=CC=C4)=C(C([O-])=O)N13 |
| For Use With (Application) | COVID-19-immunoregulation |
| Percent Purity | 98.0% |
| CAS | 72558-82-8 |
| Solubility Information | H2O : 100 mg/mL (182.96 mM; Need ultrasonic) ∣DMSO : 25 mg/mL (45.74 mM; ultrasonic and warming and heat to 80°C) |
| Health Hazard 1 | H317∣H319∣H334 |
| Synonym | GR20263 |
| Purity Grade Notes | Research |
| Recommended Storage | 4°C, protect from light∣In solvent : -80°C, 6 months∣-20°C, 1 month (protect from light) |
| Shelf Life | 4°C, protect from light∣In solvent : -80°C, 6 months∣-20°C, 1 month (protect from light) |
| Molecular Formula | C22H22N6O7S2 |
| Formula Weight | 546.58 |